DocGo Inc. (DCGO) Revenue History
Annual and quarterly revenue from 2019 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2024)
DCGO's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
DCGO Revenue Analysis (2019–2024)
As of March 1, 2026, DocGo Inc. (DCGO) generated trailing twelve-month (TTM) revenue of $368.1 million, reflecting significant decline in growth of -48.9% year-over-year. The most recent quarter (Q3 2025) recorded $70.8 million in revenue, down 11.9% sequentially.
Looking at the longer-term picture, DCGO's 5-year compound annual growth rate (CAGR) stands at +66.4%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $624.3 million in 2023.
Revenue diversification analysis shows DCGO's business is primarily driven by Mobile Health Services Segment (69%), and Transportation Services Segment (31%). With over half of revenue concentrated in Mobile Health Services Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including CHE (+4.1% YoY), OPCH (+13.0% YoY), and ADUS (+23.2% YoY), DCGO has underperformed the peer group in terms of revenue growth. Compare DCGO vs CHE →
Peer Comparison
Compare DCGO's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DCGOCurrent | $368M | -48.9% | +66.4% | 4.7% | |
| CHE | $2.5B | +4.1% | +4.0% | 13.4% | |
| OPCH | $5.6B | +13.0% | +13.3% | 6.0% | |
| ADUS | $1.4B | +23.2% | +13.2% | 9.7% | |
| AVAH | $2.0B | +11.5% | +7.9% | 6.9% | |
| EHAB | $1.0B | +1.0% | - | -11.1% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $616.6M | -1.2% | $213.6M | 34.6% | $28.7M | 4.7% |
| 2023 | $624.3M | +41.7% | $195.4M | 31.3% | $15.1M | 2.4% |
| 2022 | $440.5M | +38.2% | $154.7M | 35.1% | $21.8M | 5.0% |
| 2021 | $318.7M | +238.7% | $109.7M | 34.4% | $15.4M | 4.8% |
| 2020 | $94.1M | +94.8% | $31.3M | 33.3% | $-14,757,683 | -15.7% |
| 2019 | $48.3M | - | $13.2M | 27.3% | $-20,762,734 | -43.0% |
See DCGO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DCGO Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare DCGO vs AGIO
See how DCGO stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is DCGO's revenue growth accelerating or slowing?
DCGO revenue declined -48.9% year-over-year, contrasting with the 5-year CAGR of +66.4%. TTM revenue fell to $368M. This reverses the prior growth trend.
What is DCGO's long-term revenue growth rate?
DocGo Inc.'s 5-year revenue CAGR of +66.4% reflects the variable expansion pattern. Current YoY growth of -48.9% is below this long-term average.
How is DCGO's revenue distributed by segment?
DCGO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2024 are available for download. Segment mix reveals concentration and diversification trends.